SEC 13F Intelligence

Trv GP III, LLC / RVMD

Trv GP III, LLC’s Revolution Medicines Inc Position

Does Trv GP III, LLC own Revolution Medicines Inc (RVMD)? Not currently — the last reported position was 1.60M shares worth $38M in Q4 2022; the fund’s latest 13F (Q4 2023) no longer reports it.

Position Value
$38M
Q4 2022
Shares
1.60M
% of Portfolio
+29.95%
Quarters Held
12
position exited

Position History RVMD

Reported value by quarter
Q1 ’20: $198MQ1 ’20Q2 ’20: $285MQ3 ’20: $279MQ3 ’20Q4 ’20: $278MQ1 ’21: $253MQ1 ’21Q2 ’21: $175MQ3 ’21: $152MQ3 ’21Q4 ’21: $139MQ1 ’22: $141MQ1 ’22Q2 ’22: $99MQ3 ’22: $71MQ3 ’22Q4 ’22: $38Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 20221.60M$38M+29.95%
Q3 20223.60M$71M+31.03%
Q2 20225.10M$99M+40.69%
Q1 20225.52M$141M+38.24%
Q4 20215.52M$139M+34.79%
Q3 20215.52M$152M+28.85%
Q2 20215.52M$175M+30.61%
Q1 20215.52M$253M+32.06%
Q4 20207.02M$278M+23.88%
Q3 20208.02M$279M+23.46%
Q2 20209.02M$285M+41.58%
Q1 20209.02M$198M+53.79%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trv GP III, LLC’s full portfolio or all institutional holders of RVMD.